SCHEMBL7363986

SCHEMBL7363986

CN(C(=O)c1ccc(I)cc1)c1nc2ccccc2c(=O)o1

nearest known ligand 0.66

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ELANE P08246 8/20 0.66
C1R P00736 10/20 0.55
PRSS1 P07477 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7333539 0.91 ELANE (0.74) ELANEC1RPRSS1
SCHEMBL7365932 0.87 ELANE (0.62) ELANEC1RPRSS1
SCHEMBL7339172 0.85 ELANE (0.63) ELANEC1R
SCHEMBL7329441 0.85 ELANE (0.63) ELANEC1RPRSS1
SCHEMBL7335445 0.84 C1R (0.62) ELANEC1RPRSS1
SCHEMBL7333602 0.82 ELANE (0.66) ELANEC1RPRSS1
SCHEMBL7338273 0.82 ELANE (0.58) ELANEC1RPRSS1
SCHEMBL7367511 0.82 ELANE (0.58) ELANEC1RPRSS1
SCHEMBL8897422 0.81 ELANE (0.63) ELANEC1RPRSS1
SCHEMBL7337764 0.81 ELANE (0.63) ELANEC1RPRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5652237-A 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes WARNER-LAMBERT COMPANY (US) 1997-07-29 US disclosed
WO-1996007648-A1 2-SUBSTITUTED-4H-3,1-BENZOXAZIN-4-ONES AND BENZTHIAZIN-4-ONES AS INHIBITORS OF COMPLEMENT Clr PROTEASE FOR THE TREATMENT OF INFLAMMATORY PROCESSES WARNER-LAMBERT COMPANY (US) 1996-03-14 WO disclosed